Home › Trials › NCT05152238

Registry for patients with Immune Thrombocytopenia and biospecimen collection

Multicenter National ITP Registry and Accompanying Biospecimen Collection

Observational Jena University Hospital · NCT05152238

This study is collecting health information and samples from people with Immune Thrombocytopenia to better understand the condition and improve treatment options.

Quick facts

Study typeObservational
Enrollment1100 (estimated)
Ages18 Years and up
SexAll
SponsorJena University Hospital Academic / other
Locations64 sites (Aachen and 63 other locations)
Trial IDNCT05152238 on ClinicalTrials.gov

What this trial studies

This registry aims to collect clinical information and biospecimens from patients diagnosed with Immune Thrombocytopenia (ITP) at various stages of their disease. By gathering real-world data, the registry seeks to enhance understanding of ITP diagnosis and treatment, ultimately guiding patients to more effective therapies. The study will collect a wide range of clinical measures, treatment outcomes, and quality of life data over a period of up to five years. Patients can be included both prospectively and retrospectively, provided they meet the eligibility criteria and have continuous documentation.

Who should consider this trial

Good fit: Ideal candidates for this registry are adults aged 18 and older diagnosed with primary or secondary Immune Thrombocytopenia.

Not a fit: Patients with diagnoses that cannot be reconciled with ITP or those unable to provide informed consent may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could lead to improved treatment strategies and outcomes for patients with Immune Thrombocytopenia.

How similar studies have performed: Other studies utilizing real-world data collection for ITP have shown promise in improving patient outcomes, making this approach both relevant and potentially impactful.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Primary or secondary Immune Thrombocytopenia (ITP)
* Age ≥18 years
* signed declaration of consent

Exclusion Criteria:

* diagnoses that cannot be reconciled with the diagnosis of ITP (esp. heparin-induced thrombocytopenia, pregnancy-associated thrombocytopenia, pseudothrombocytopenia)
* no informed consent possible (this covers patients who are unable to understand the nature and scope of participation)

Where this trial is running

Aachen and 63 other locations

+14 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Immune Thrombocytopenia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.